US biotech companies Bambusa Therapeutics and Aspen Neuroscience have filed for initial public offerings (IPOs), seeking ...

Canadian eye health company Bausch + Lomb (NYSE: BLCO) has appointed Thomas Appio interim chief executive following an ...

Governor Josh Shapiro and Department of Community and Economic Development (DCED) Secretary Rick Siger announced the ...

Uptake of new cancer medicines still differs more than three-fold between European countries, though the gap has narrowed ...

ANI Pharmaceuticals today announced that both 6-month and 24-month data from SYNCHRONICITY, its Phase IV, open-label, ...

Concept Life Sciences, specializing in integrated drug discovery, development and analytical services, today announced the ...

Chai Discovery, the San Francisco-based AI company building computer-aided design tools for molecules, has announced a ...

The Food and Drug Administration (FDA) has approved Hovilpri (pritelivir) 100mg tablets for the treatment of mucocutaneous ...

Key analyses from the positive Phase III OBERON and TITANIA trials and results from the PROSPERO long-term extension trial ...

Innovent Biologics, the Chinese biopharma company, said its anti-IGF-1R antibody Sycume (teprotumumab N01 injection; IBI311) met its primary endpoint in the Phase III RESTORE-3 trial in Chinese ...

Antibody-drug conjugates (ADCs) bring together two familiar approaches to cancer treatment: an antibody that recognizes a ...

US biotech City Therapeutics is seeking about $175 million in an initial public offering (IPO) to support three experimental ...